{"@context":"http://iiif.io/api/presentation/2/context.json","@type":"sc:Manifest","@id":"https://iiif.quartexcollections.com/portland/iiif/9cc2b0a2-3137-4cc4-a190-06645ed0d477/manifest","label":"Expression in Aromatase Inhibitor Responder vs. Non-Responder HR+","metadata":[{"label":"Title","value":"Expression in Aromatase Inhibitor Responder vs. Non-Responder HR+ Breast Cancer Cohorts"},{"label":"Relation","value":"bio"},{"label":"Author","value":"Jeffrey Hayashi"},{"label":"Abstract","value":"Hormone receptor positive (HR+) breast cancer patients have an excellent prognosis with over 85% cure rates. However, 20,000 women with HR+ breast cancer die annually from tumor recurrence. Those at highest risk for recurrence are those women whose tumors continue to proliferate through estrogen blockade (Figure 4). Addition of chemotherapy for these patients failed to improve outcomes. We retrospectively identified women with HR+ breast cancer treated neoadjuvantly with aromatase inhibitors (AI), and selected matched patient cohorts for responders and non-responders determined by post-AI Ki67 of"},{"label":"Publication Information","value":"Copyright for this work is retained by the author. 2018 Summer Research Celebration Project."},{"label":"Sponsor","value":"Providence Cancer Center, Earle A. Chiles Research Institute, University of Portland, The Oregon Clinic"},{"label":"Document Type","value":["student project"]},{"label":"Undergraduate Collection","value":["Biology Student Works"]},{"label":"Department","value":["Biology"]},{"label":"College & School","value":["College of Arts and Sciences"]},{"label":"Faculty Advisor","value":["Dr. Kristina Young"]},{"label":"Publication Date","value":"D:00 M:00 Y:2018"}],"description":"Expression in Aromatase Inhibitor Responder vs. Non-Responder HR+ Breast Cancer Cohorts","sequences":[{"@type":"sc:Sequence","canvases":[{"@id":"https://iiif.quartexcollections.com/portland/iiif/9cc2b0a2-3137-4cc4-a190-06645ed0d477/canvas/_1","@type":"sc:Canvas","label":"Expression in Aromatase Inhibitor Responder vs. Non-Responder HR+-3","height":5400,"width":7201,"images":[{"@type":"oa:Annotation","motivation":"sc:painting","resource":{"@id":"https://iiif.quartexcollections.com/portland/iiif/0d34d4f8-a5f8-4b91-bffb-cefbada6acec/full/full/0/default.jpg","@type":"dctypes:Image","format":"image/jpeg","service":{"@context":"http://iiif.io/api/image/2/context.json","@id":"https://iiif.quartexcollections.com/portland/iiif/0d34d4f8-a5f8-4b91-bffb-cefbada6acec","profile":"http://iiif.io/api/image/2/level2.json","tiles":[{"width":2048,"scaleFactors":[1,2,4]}]},"height":5400,"width":7201},"on":"https://iiif.quartexcollections.com/portland/iiif/9cc2b0a2-3137-4cc4-a190-06645ed0d477/canvas/_1","metadata":[]}],"thumbnail":{"@id":"https://iiif.quartexcollections.com/portland/iiif/0d34d4f8-a5f8-4b91-bffb-cefbada6acec/full/500,500/0/default.jpg","@type":"dctypes:Image","height":500,"width":500}}]}],"thumbnail":"https://iiif.quartexcollections.com/portland/iiif/0d34d4f8-a5f8-4b91-bffb-cefbada6acec/full/300,300/0/default.jpg","logo":"https://iiif.quartexcollections.com/portland/iiif/logo"}